Healthcare Global Enterprises Limited has announced board approval for a rights issue of fully paid-up equity shares worth up to ₹42,500 Lakhs. The issue will be offered to eligible shareholders as of a record date to be determined, subject to regulatory and statutory approvals.
Healthcare Global Enterprises Limited (HCG), a leading provider of cancer care and specialty healthcare services, has confirmed that its board of directors has approved a rights issue of equity shares. The decision was taken at the board meeting held on February 17, 2026, following the earlier intimation dated February 8, 2026.
Key Highlights
-
The rights issue will involve fully paid-up equity shares of face value ₹10 each
-
The total amount to be raised will not exceed ₹42,500 Lakhs
-
Eligible shareholders as of the record date (to be announced) will be entitled to participate
-
Detailed terms including issue price, entitlement ratio, record date, and payment schedule will be finalized by the Rights Issue Committee
-
The issuance is subject to compliance with SEBI (ICDR) Regulations, 2018, and other applicable statutory approvals
-
The move is expected to strengthen the company’s capital base and support future growth initiatives
Sources: Healthcare Global Enterprises Limited, BSE Filing, NSE Announcement